课题基金 / 基金详情

Synthesis of Small-Molecule Inhibitors Targeting Bromodomain Containing Proteins

Synthesis of Small-Molecule Inhibitors Targeting Bromodomain Containing Proteins
靶向含溴结构域蛋白的小分子抑制剂的合成
批准号:
533881-2018
负责人:
Gagnon, Alexandre
金额:
$1.82万
依托单位国家:
加拿大
项目类别:
Engage Grants Program
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Gagnon, Alexandre的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The genetic information of an organism is contained within its DNA sequence. In order to fit inside the nucleus of a cell, DNA wraps itself around an octamer of proteins called histones, resulting in formation of chromatin. Epigenetic transformations, which consist in the installation of marks on DNA and histone tails, affect the level of compaction of chromatin, resulting in gene activation or silencing. Lysine acetylation is an epigenetic transformation that leads to the removal of the positive charge on the amino group of the lysine side chain thus preventing the formation of electrostatic interactions with the phosphate groups of DNA and resulting in gene transcription. Bromodomains are reader epigenetic proteins that bind to acetylated lysines to recruit transcription factors and promote gene transcription. A few bromodomain inhibitors have been reported and used as chemical probes to better understand the role of these proteins in chromatin remodeling and gene expression. However, because these compounds are all chemically related, they present similar liabilities in terms of target specificity and biopharmaceutical properties. Zenith Epigenetics is a biotechnology company with an expertise on the development of bromodomain inhibitors. To maintain their competitiveness, they must identify new targets and novel compounds that interact with them to modulate their activity. Recently, a new bromodomain containing protein (BCP) has been identified by Zenith Epigenetics, along with two molecules that bind to these proteins to interfere with their function. However, the chemical complexity of these compounds and the preparation of derivatives with increased potency requires an advanced expertise in organic synthesis and in medicinal chemistry. The goal of this project is to design and synthesize potent and selective inhibitors of BCPs that will serve as chemical probes to investigate the biochemical role of these proteins in chromatin remodeling and gene expression.**********
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Expanding the Scope of Organobismuth Compounds in Organic Synthesis
  • 批准号:
    RGPIN-2017-05605
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.6万
  • 财政年份:
    2022
  • 负责人:
    Gagnon, Alexandre
  • 依托单位:
Expanding the Scope of Organobismuth Compounds in Organic Synthesis
  • 批准号:
    RGPIN-2017-05605
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.6万
  • 财政年份:
    2021
  • 负责人:
    Gagnon, Alexandre
  • 依托单位:
Expanding the Scope of Organobismuth Compounds in Organic Synthesis
  • 批准号:
    RGPIN-2017-05605
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.6万
  • 财政年份:
    2020
  • 负责人:
    Gagnon, Alexandre
  • 依托单位:
Expanding the Scope of Organobismuth Compounds in Organic Synthesis
  • 批准号:
    RGPIN-2017-05605
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.6万
  • 财政年份:
    2019
  • 负责人:
    Gagnon, Alexandre
  • 依托单位:
国内基金
海外基金
昼夜节律性small RNA在血斑形成时间推断中的法医学应用研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
  • 依托单位:
tRNA-derived small RNA上调YBX1/CCL5通路参与硼替佐米诱导慢性疼痛的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    张祥忠
  • 依托单位:
Small RNA调控I-F型CRISPR-Cas适应性免疫性的应答及分子机制
Small RNAs调控解淀粉芽胞杆菌FZB42生防功能的机制研究
  • 批准号:
    31972324
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    高学文
  • 依托单位: